Modern targeted therapeutics are designed to intervene in a bespoke way with disease processes. They are artworks of biotechnology, designed for focused efficacy, and improved tolerability profiles for patients. Everything about them is thoughtful; their size, binding sites, active and inactivated elements, choice of antigens, residues, toxins, and linkers. Even proportions come into play when directing cells to interact. Spending the time required to understand the biology in depth makes it possible to anticipate clinical plans and regulatory questions.

Translating data into evidence improves standards of care. This does not need to be complicated. When finding the simple, most impactful way to communicate medicine, advocacy comes almost automatically. Asking questions like, “What makes this unique?” and “How can I understand the way it works? “draws audiences in.